ID=wsj_2007.1 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD Three N_156/N_156>) (<T N 1 2> (<L N/N VBG VBG leading N_149/N_149>) (<T N 1 2> (<L N/N NN NN drug N_142/N_142>) (<L N NNS NNS companies N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD reported (S[dcl]\NP_8)/NP_9>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ robust N_25/N_25>) (<T N 1 2> (<L N/N NN NN third-quarter N_18/N_18>) (<L N NNS NNS earnings N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN bolstered S[pss]\NP_33>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_46\NP_41)_46\(S_46\NP_41)_46)/NP_47>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ strong N_56/N_56>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_65\NP_65)/NP_66>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJR JJR newer N_91/N_91>) (<T N 1 2> (<L , , , , ,>) (<T N 1 2> (<L N/N JJ JJ big-selling N_82/N_82>) (<T N 1 2> (<L N/N NNS NNS prescriptions N_75/N_75>) (<L N NNS NNS drugs N>) ) ) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT that (NP_102\NP_102)/(S[dcl]_103\NP_102:B)_103>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBP VBP provide (S[dcl]\NP_110)/NP_111>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ hefty N_127/N_127>) (<T N 1 2> (<L N/N NN NN profit N_120/N_120>) (<L N NNS NNS margins N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.2 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Merck N_197/N_197>) (<T N 1 2> (<L N/N CC CC & N_190/N_190>) (<L N NNP NNP Co. N>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD reported (S[dcl]\NP_140)/NP_141>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_169/N_169>) (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) CD CD 25 (N_164/N_158)_164/(N_164/N_158)_164>) (<L N/N NN NN % N_150/N_150>) ) (<L N NN NN increase N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_177\NP_177)/NP_178>) (<T NP 0 1> (<L N NNS NNS earnings N>) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L ; ; : ; ;>) (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Warner-Lambert N_257/N_257>) (<L N NNP NNP Co. N>) ) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_247/N_247)\NP_248>) ) (<L N NN NN profit N>) ) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_203>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 22 ((S_238\NP_230)_238\(S_231\NP_230)_231)_238/((S_238\NP_230)_238\(S_231\NP_230)_231)_238>) (<L (S\NP)\(S\NP) NN NN % (S_215\NP_210)_215\(S_215\NP_210)_215>) ) ) ) (<T S[dcl][conj] 1 2> (<L conj CC CC and conj>) (<T S[dcl] 1 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Eli N_338/N_338>) (<T N 1 2> (<L N/N NNP NNP Lilly N_331/N_331>) (<T N 1 2> (<L N/N CC CC & N_324/N_324>) (<L N NNP NNP Co. N>) ) ) ) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_314/N_314)\NP_315>) ) (<T N 1 2> (<L N/N JJ JJ net N_307/N_307>) (<L N NN NN income N>) ) ) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_263>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 24 ((S_298\NP_290)_298\(S_291\NP_290)_291)_298/((S_298\NP_290)_298\(S_291\NP_290)_291)_298>) (<L (S\NP)\(S\NP) NN NN % (S_275\NP_270)_275\(S_275\NP_270)_275>) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.3 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_234/N_234>) (<L N NNS NNS results N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/PP VBD VBD were (S[dcl]\NP_196)/PP_197>) (<T PP 0 2> (<L PP/NP IN IN in PP/NP_202>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN line N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN with (NP_213\NP_213)/NP_214>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNS NNS analysts N>) ) (<L (NP[nb]/N)\NP POS POS ' (NP[nb]_223/N_223)\NP_224>) ) (<L N NNS NNS expectations N>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.4 PARSER=GOLD NUMPARSE=1
(<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Merck N_54/N_54>) (<T N 1 2> (<L N/N CC CC & N_47/N_47>) (<T N 0 2> (<L N NNP NNP Co N>) (<L . . . . .>) ) ) ) ) 
ID=wsj_2007.5 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NNP NNP Merck N>) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L NP\NP NNP NNP Rahway NP_131\NP_131>) (<T NP\NP[conj] 1 2> (<L , , , , ,>) (<L NP\NP NNP NNP N.J. NP_138\NP_138>) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBD VBD continued (S[dcl]\NP_24)/(S[to]_25\NP_24:B)_25>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_34)/(S[b]_35\NP_34:B)_35>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB lead (S[b]\NP_42)/NP_43>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_50/N_50>) (<L N NN NN industry N>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN with ((S_63\NP_58)_63\(S_63\NP_58)_63)/NP_64>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_85/N_85>) (<T N 1 2> (<L N/N JJ JJ strong N_80/N_80>) (<T N 1 2> (<L N/N NNS NNS sales N_73/N_73>) (<L N NN NN performance N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_93\NP_93)/NP_94>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_119/N_119>) (<T N 1 2> (<L N NN NN human N>) (<T N[conj] 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N NN NN animal N_110/N_110>) (<T N 1 2> (<L N/N NNS NNS health-products N_103/N_103>) (<L N NN NN segment N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.6 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT A NP[nb]_261/N_261>) (<T N 1 2> (<L N/N JJR JJR stronger N_256/N_256>) (<T N 1 2> (<L N/N NNP NNP U.S. N_249/N_249>) (<L N NN NN dollar N>) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD reduced (S[dcl]\NP_116)/NP_117>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN third-quarter N_142/N_142>) (<T N 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N JJ JJ first-nine-month N_133/N_133>) (<T N 1 2> (<L N/N NNS NNS sales N_126/N_126>) (<L N NN NN growth N>) ) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 2 ((S_178\NP_170)_178\(S_171\NP_170)_171)_178/((S_178\NP_170)_178\(S_171\NP_170)_171)_178>) (<L (S\NP)\(S\NP) NN NN % (S_155\NP_150)_155\(S_155\NP_150)_155>) ) (<T (S\NP)\(S\NP)[conj] 1 2> (<L conj CC CC and conj>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 3 ((S_213\NP_205)_213\(S_206\NP_205)_206)_213/((S_213\NP_205)_213\(S_206\NP_205)_206)_213>) (<L (S\NP)\(S\NP) NN NN % (S_190\NP_185)_190\(S_190\NP_185)_190>) ) ) ) (<L , , , , ,>) ) (<L ((S\NP)\(S\NP))\((S\NP)\(S\NP)) RB RB respectively ((S_240\NP_232)_240\(S_233\NP_232)_233)_240\((S_240\NP_232)_240\(S_233\NP_232)_233)_240>) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.7 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ International N_270/N_270>) (<L N NNS NNS sales N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/PP VBD VBD accounted (S[dcl]\NP_149)/PP_150>) (<T PP 0 2> (<L PP/NP IN IN for PP/NP_155>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 47 N_164/N_164>) (<L N NN NN % N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_173\NP_173)/NP_174>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ total N_190/N_190>) (<T N 1 2> (<L N/N NN NN company N_183/N_183>) (<L N NNS NNS sales N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_199\NP_199)/NP_200>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_214/N_214>) (<T N 1 2> (<L N/N CD CD nine N_209/N_209>) (<L N NNS NNS months N>) ) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/PP VBN VBN compared ((S_229\NP_224)_229\(S_229\NP_224)_229)/PP_230>) (<T PP 0 2> (<T PP 0 2> (<L PP/NP IN IN with PP/NP_235>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 50 N_244/N_244>) (<L N NN NN % N>) ) ) ) (<T PP\PP 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_261/N_261>) (<L N NN NN year N>) ) (<L (PP\PP)\NP RBR RBR earlier (PP_253\PP_253)\NP_254>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.8 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS Sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_186\NP_186)/NP_187>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_194/N_194>) (<L N NN NN quarter N>) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_117>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_130\NP_125)_130\(S_130\NP_125)_130)/NP_131>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_136>) (<T N[num] 1 2> (<L N/N CD CD 1.63 N_145/N_145>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN from ((S_159\NP_154)_159\(S_159\NP_154)_159)/NP_160>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_165>) (<T N[num] 1 2> (<L N/N CD CD 1.47 N_174/N_174>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.9 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NNP NNP Mevacor N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Merck N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_244/N_244)\NP_245>) ) (<T N 1 2> (<L N/N JJ JJ new N_237/N_237>) (<T N 1 2> (<L N/N JJ JJ cholesterol-lowering N_230/N_230>) (<L N NN NN drug N>) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD had (S[dcl]\NP_96)/NP_97>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJR JJR higher N_106/N_106>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/S[dcl] IN IN than (NP_115\NP_115)/S[dcl]_116>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT any NP[nb]_218/N_218>) (<T N 1 2> (<L N/N JJ JJ other N_213/N_213>) (<T N 1 2> (<L N/N NN NN prescription N_206/N_206>) (<L N NN NN medicine N>) ) ) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[pt]\NP) 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_125)/(S[pt]_126\NP_125:B)_126>) (<L (S\NP)\(S\NP) RB RB ever (S_138\NP_133)_138\(S_138\NP_133)_138>) ) (<T S[pt]\NP 0 2> (<T S[pt]\NP 0 2> (<L S[pt]\NP VBN VBN achieved S[pt]\NP_143>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_156\NP_151)_156\(S_156\NP_151)_156)/NP_157>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_164/N_164>) (<L N NNP NNP U.S. N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_177\NP_172)_177\(S_177\NP_172)_177)/NP_178>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_185/N_185>) (<L N NN NN year N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP VBG VBG following (NP_193\NP_193)/NP_194>) (<T NP 0 1> (<L N NN NN introduction N>) ) ) ) ) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_87/N_87>) (<L N NN NN company N>) ) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_79)\NP_80>) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.10 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_215/N_215>) (<L N NN NN drug N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBD VBD was (S[dcl]\NP_162)/(S[pss]_163\NP_162:B)_163>) (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN introduced S[pss]\NP_168>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_181\NP_176)_181\(S_181\NP_176)_181)/NP_182>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP West N_191/N_191>) (<L N NNP NNP Germany N>) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/N DT DT this ((S_205\NP_200)_205\(S_205\NP_200)_205)/N_206>) (<L N NN NN year N>) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.11 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Intense N_196/N_196>) (<L N NN NN competition N>) ) ) (<T S[dcl]\NP 1 2> (<L , , , , ,>) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB however (S_185\NP_180)_185/(S_185\NP_180)_185>) (<T S[dcl]\NP 1 2> (<L , , , , ,>) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD led S[dcl]\NP_61>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_74\NP_69)_74\(S_74\NP_69)_74)/NP_75>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN unit N_91/N_91>) (<T N 1 2> (<L N/N NNS NNS sales N_84/N_84>) (<L N NNS NNS declines N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_100\NP_100)/NP_101>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_108/N_108>) (<L N NN NN group N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_116\NP_116)/NP_117>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Merck N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_149/N_149)\NP_150>) ) (<T N 1 2> (<L N/N VBN VBN established N_142/N_142>) (<T N 1 2> (<L N/N NN NN human N_135/N_135>) (<T N 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N NN NN animal-health N_126/N_126>) (<L N NNS NNS products N>) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP VBG VBG including (NP_163\NP_163)/NP_164>) (<T NP 0 1> (<T N 1 2> (<L N NNP NNP Aldomet N>) (<T N[conj] 1 2> (<L conj CC CC and conj>) (<L N NNP NNP Indocin N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.12 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/NP IN IN In (S_188/S_188)/NP_189>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP New N_226/N_226>) (<T N 1 2> (<L N/N NNP NNP York N_219/N_219>) (<T N 1 2> (<L N/N NNP NNP Stock N_212/N_212>) (<T N 1 2> (<L N/N NNP NNP Exchange N_205/N_205>) (<T N 1 2> (<L N/N JJ JJ composite N_198/N_198>) (<L N NN NN trading N>) ) ) ) ) ) ) ) (<T S[dcl] 1 2> (<L S/S NN NN yesterday S_180/S_180>) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN Merck N_170/N_170>) (<L N NNS NNS shares N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/PP VBD VBD closed (S[dcl]\NP_121)/PP_122>) (<T PP 0 2> (<L PP/NP IN IN at PP/NP_127>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_132>) (<L N[num] CD CD 75.25 N[num]>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN up ((S_150\NP_145)_150\(S_150\NP_145)_150)/NP_151>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 50 N_160/N_160>) (<L N NNS NNS cents N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.13 PARSER=GOLD NUMPARSE=1
(<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Warner-Lambert N_109/N_109>) (<T N 0 2> (<L N NNP NNP Co N>) (<L . . . . .>) ) ) ) 
ID=wsj_2007.14 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<L N NNP NNP Warner-Lambert N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Morris N_149/N_149>) (<L N NNP NNP Plains N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 1> (<L N NNP NNP N.J. N>) ) ) ) (<L , , , , ,>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD reported (S[dcl]\NP_15)/NP_16>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT that (NP_29\NP_29)/(S[dcl]_30\NP_29:B)_30>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD were (S[dcl]\NP_37)/NP_38>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_45/N_45>) (<L N NN NN record N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_53\NP_53)/NP_54>) (<T NP 1 2> (<L NP[nb]/N DT DT any NP[nb]_61/N_61>) (<L N NN NN quarter N>) ) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_75/N_75>) (<T N 1 2> (<L N/N JJ JJ eighth N_70/N_70>) (<L N NN NN quarter N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_83\NP_83)/NP_84>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_91/N_91>) (<L N NN NN row N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_99\NP_99)/NP_100>) (<T NP 1 2> (<T NP[nb]/N 0 2> (<T NP[nb]/N 1 2> (<L NP/NP CD CD 20 NP_128/NP_128>) (<L NP[nb]/N NN NN % NP[nb]_121/N_121>) ) (<T NP[nb]/N[conj] 1 2> (<L conj CC CC or conj>) (<L NP[nb]/N JJR JJR more NP[nb]_133/N_133>) ) ) (<T N 1 2> (<L N/N JJ JJ per-share N_116/N_116>) (<T N 1 2> (<L N/N NNS NNS earnings N_109/N_109>) (<L N NN NN growth N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.15 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S/S 0 1> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN Spurred S[pss]\NP_309>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_322\NP_317)_322\(S_322\NP_317)_322)/NP_323>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN growth N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_334\NP_334)/NP_335>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ world-wide N_344/N_344>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_353\NP_353)/NP_354>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_378/N_378>) (<L N NN NN company N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_370/N_370)\NP_371>) ) (<T N 1 2> (<L N/N NN NN prescription N_363/N_363>) (<L N NNS NNS drugs N>) ) ) ) ) ) ) ) ) ) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Warner-Lambert N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_127)/S[dcl]_128>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N CD CD 1989 N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD will (S[dcl]\NP_137)/(S[b]_138\NP_137:B)_138>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB be (S[b]\NP_145)/NP_146>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_160/N_160>) (<T N 1 2> (<L N/N JJS JJS best N_155/N_155>) (<L N NN NN year N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_168\NP_168)/NP_169>) (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ its NP[nb]_176/N_176>) (<L N NN NN history N>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<T ((S\NP)\(S\NP))/(S[pt]\NP) 0 2> (<L (((S\NP)\(S\NP))/(S[pt]\NP))/NP IN IN with (((S_195\NP_187)_195\(S_195\NP_187)_195)/(S[pt]_196\NP_190:B)_196)/NP_190>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ per-share N_206/N_206>) (<L N NNS NNS earnings N>) ) ) ) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/(S[to]\NP) VBN VBN expected (S[pt]\NP_216)/(S[to]_217\NP_216:B)_217>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_226)/(S[b]_227\NP_226:B)_227>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB increase (S[b]\NP_234)/NP_235>) (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<T (N/N)/(N/N) 1 2> (<L S[adj]\NP JJR JJR more S[adj]\NP_266>) (<L ((N/N)/(N/N))\(S[adj]\NP) IN IN than ((N_260/N_252)_260/(N_260/N_252)_260)\(S[adj]_261\NP_255)_261>) ) (<L N/N CD CD 20 N_244/N_244>) ) (<L N NN NN % N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_280\NP_275)_280\(S_280\NP_275)_280)/NP_281>) (<T NP 0 1> (<T N 1 2> (<L N/N IN IN about N_295/N_295>) (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_286>) (<L N[num] CD CD 6.10 N[num]>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.16 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS Sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_290\NP_290)/NP_291>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_298/N_298>) (<L N NN NN quarter N>) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_221>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_234\NP_229)_234\(S_234\NP_229)_234)/NP_235>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_240>) (<T N[num] 1 2> (<L N/N CD CD 1.11 N_249/N_249>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN from ((S_263\NP_258)_263\(S_263\NP_258)_263)/NP_264>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_269>) (<T N[num] 1 2> (<L N/N CD CD 1.03 N_278/N_278>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.17 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN Prescription-drug N_178/N_178>) (<T N 1 2> (<L N/N JJ JJ world-wide N_171/N_171>) (<L N NNS NNS sales N>) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_77>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 9 ((S_112\NP_104)_112\(S_105\NP_104)_105)_112/((S_112\NP_104)_112\(S_105\NP_104)_105)_112>) (<L (S\NP)\(S\NP) NN NN % (S_89\NP_84)_89\(S_89\NP_84)_89>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_125\NP_120)_125\(S_125\NP_120)_125)/NP_126>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_133/N_133>) (<L N NN NN quarter N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_146\NP_141)_146\(S_146\NP_141)_146)/NP_147>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_152>) (<T N[num] 1 2> (<L N/N CD CD 340 N_161/N_161>) (<L N[num] CD CD million N[num]>) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L ; ; : ; ;>) (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP U.S. N_228/N_228>) (<L N NNS NNS sales N>) ) ) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_184>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 15 ((S_219\NP_211)_219\(S_212\NP_211)_212)_219/((S_219\NP_211)_219\(S_212\NP_211)_212)_219>) (<L (S\NP)\(S\NP) NN NN % (S_196\NP_191)_196\(S_196\NP_191)_196>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.18 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_284/N_284>) (<L N NN NN segment N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_276/N_276)\NP_277>) ) (<L N NN NN growth N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBD VBD was (S[dcl]\NP_156)/(S[pss]_157\NP_156:B)_157>) (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN led S[pss]\NP_162>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_175\NP_170)_175\(S_175\NP_170)_175)/NP_176>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_187\NP_187)/NP_188>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_202/N_202>) (<T N 1 2> (<L N/N JJ JJ cardiovascular N_197/N_197>) (<L N NNS NNS drugs N>) ) ) (<T NP\NP 0 2> (<T NP\NP 0 2> (<L NP\NP NNP NNP Lopid NP_209\NP_209>) (<T NP\NP[conj] 1 2> (<L , , , , ,>) (<T NP\NP 0 2> (<L (NP\NP)/N DT DT a (NP_217\NP_217)/N_218>) (<T N 1 2> (<L N/N NN NN lipid N_227/N_227>) (<L N NN NN regulator N>) ) ) ) ) (<T NP\NP[conj] 1 2> (<L , , , , ,>) (<T NP\NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP\NP 0 2> (<L NP\NP NNP NNP Dilzem NP_236\NP_236>) (<T NP\NP[conj] 1 2> (<L , , , , ,>) (<T NP\NP 0 2> (<L (NP\NP)/N DT DT a (NP_244\NP_244)/N_245>) (<T N 1 2> (<L N/N NN NN calcium N_261/N_261>) (<T N 1 2> (<L N/N NN NN channel N_254/N_254>) (<L N NN NN blocker N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.19 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ World-wide N_223/N_223>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_232\NP_232)/NP_233>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Warner-Lambert N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_256/N_256)\NP_257>) ) (<T N 1 2> (<L N/N JJ JJ non-prescription N_249/N_249>) (<T N 1 2> (<L N/N NN NN health-care N_242/N_242>) (<L N NNS NNS products N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 1 2> (<L (NP\NP)/(NP\NP) JJ JJ such (NP_335\NP_329)_335/(NP_335\NP_329)_335>) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN as (NP_270\NP_270)/NP_271>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Halls N_287/N_287>) (<T N 1 2> (<L N/N NN NN cough N_280/N_280>) (<L N NNS NNS tablets N>) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Rolaids N_297/N_297>) (<L N NN NN antacid N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Lubriderm N_314/N_314>) (<T N 1 2> (<L N/N NN NN skin N_307/N_307>) (<L N NN NN lotion N>) ) ) ) ) ) ) ) ) ) ) ) (<L , , , , ,>) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD increased S[dcl]\NP_122>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 3 ((S_157\NP_149)_157\(S_150\NP_149)_150)_157/((S_157\NP_149)_157\(S_150\NP_149)_150)_157>) (<L (S\NP)\(S\NP) NN NN % (S_134\NP_129)_134\(S_134\NP_129)_134>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_170\NP_165)_170\(S_170\NP_165)_170)/NP_171>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_176>) (<T N[num] 1 2> (<L N/N CD CD 362 N_185/N_185>) (<L N[num] CD CD million N[num]>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_199\NP_194)_199\(S_199\NP_194)_199)/NP_200>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_214/N_214>) (<T N 1 2> (<L N/N JJ JJ third N_209/N_209>) (<L N NN NN quarter N>) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L ; ; : ; ;>) (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP U.S. N_386/N_386>) (<L N NNS NNS sales N>) ) ) (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_342>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 5 ((S_377\NP_369)_377\(S_370\NP_369)_370)_377/((S_377\NP_369)_377\(S_370\NP_369)_370)_377>) (<L (S\NP)\(S\NP) NN NN % (S_354\NP_349)_354\(S_354\NP_349)_354>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.20 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Confectionery N_303/N_303>) (<T N 1 2> (<L N/N NNS NNS products N_296/N_296>) (<L N NNS NNS sales N>) ) ) ) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB also (S_287\NP_282)_287/(S_287\NP_282)_287>) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD had (S[dcl]\NP_243)/NP_244>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ strong N_253/N_253>) (<L N NN NN growth N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_267\NP_262)_267\(S_267\NP_262)_267)/NP_268>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_275/N_275>) (<L N NN NN quarter N>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.21 PARSER=GOLD NUMPARSE=1
(<T S[b] 0 2> (<T S[b] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ World-wide N_139/N_139>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_148\NP_148)/NP_149>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Trident N_158/N_158>) (<L N NN NN gum N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Certs N_175/N_175>) (<T N 1 2> (<L N/N NN NN breath N_168/N_168>) (<L N NNS NNS mints N>) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Clorets N_201/N_201>) (<T N 1 2> (<L N/N NN NN gum N_194/N_194>) (<T N 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N NN NN breath N_185/N_185>) (<L N NNS NNS mints N>) ) ) ) ) ) ) ) ) ) ) (<L , , , , ,>) ) ) ) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L S[b]\NP VB VB increased S[b]\NP_66>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 12 ((S_101\NP_93)_101\(S_94\NP_93)_94)_101/((S_101\NP_93)_101\(S_94\NP_93)_94)_101>) (<L (S\NP)\(S\NP) NN NN % (S_78\NP_73)_78\(S_78\NP_73)_78>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_114\NP_109)_114\(S_114\NP_109)_114)/NP_115>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_120>) (<T N[num] 1 2> (<L N/N CD CD 277 N_129/N_129>) (<L N[num] CD CD million N[num]>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.22 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Warner-Lambert N_242/N_242>) (<L N NNS NNS shares N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/PP VBD VBD closed (S[dcl]\NP_132)/PP_133>) (<T PP 0 2> (<L PP/NP IN IN at PP/NP_138>) (<T NP 0 2> (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_143>) (<L N[num] CD CD 109.50 N[num]>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/N DT DT a (NP_154\NP_154)/N_155>) (<L N NN NN share N>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN up ((S_172\NP_167)_172\(S_172\NP_167)_172)/NP_173>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_178>) (<L N[num] CD CD 1.50 N[num]>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_196\NP_191)_196\(S_196\NP_191)_196)/NP_197>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Big N_220/N_220>) (<T N 1 2> (<L N/N NNP NNP Board N_213/N_213>) (<T N 1 2> (<L N/N JJ JJ composite N_206/N_206>) (<L N NN NN trading N>) ) ) ) ) ) ) (<L (S\NP)\(S\NP) NN NN yesterday (S_233\NP_228)_233\(S_233\NP_228)_233>) ) ) (<L . . . . .>) ) 
ID=wsj_2007.23 PARSER=GOLD NUMPARSE=1
(<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Eli N_126/N_126>) (<T N 1 2> (<L N/N NNP NNP Lilly N_119/N_119>) (<T N 1 2> (<L N/N CC CC & N_112/N_112>) (<T N 0 2> (<L N NNP NNP Co N>) (<L . . . . .>) ) ) ) ) ) 
ID=wsj_2007.24 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Lilly N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L ((S[dcl]\NP)/PP)/NP VBD VBD attributed ((S[dcl]\NP_31)/PP_32)/NP_33>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN record N_58/N_58>) (<T N 1 2> (<L N/N JJ JJ third-quarter N_51/N_51>) (<T N 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N JJ JJ nine-month N_42/N_42>) (<L N NNS NNS results N>) ) ) ) ) ) ) (<T PP 0 2> (<L PP/NP TO TO to PP/NP_64>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ world-wide N_73/N_73>) (<L N NNS NNS gains N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_82\NP_82)/NP_83>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS pharmaceuticals N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ medical N_95/N_95>) (<L N NNS NNS instruments N>) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN plant-science N_105/N_105>) (<L N NNS NNS products N>) ) ) ) ) ) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN despite (NP_118\NP_118)/NP_119>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ poor N_135/N_135>) (<T N 1 2> (<L N/N NN NN exchange N_128/N_128>) (<L N NNS NNS rates N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_144\NP_144)/NP_145>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_152/N_152>) (<L N NN NN dollar N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT that (NP_162\NP_162)/(S[dcl]_163\NP_162:B)_163>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD slowed (S[dcl]\NP_170)/NP_171>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS sales N>) ) (<L NP\NP RB RB abroad NP_181\NP_181>) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.25 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS Earnings N>) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[to]\NP) VBD VBD continued (S[dcl]\NP_140)/(S[to]_141\NP_140:B)_141>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_150)/(S[b]_151\NP_150:B)_151>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB pace (S[b]\NP_158)/NP_159>) (<T NP 0 1> (<L N NNS NNS sales N>) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/PP IN IN because ((S_175\NP_170)_175\(S_175\NP_170)_175)/PP_176>) (<T PP 0 2> (<L PP/NP IN IN of PP/NP_181>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_202/N_202>) (<T N 1 2> (<L N/N JJR JJR lower N_197/N_197>) (<T N 1 2> (<L N/N NN NN tax N_190/N_190>) (<L N NN NN rate N>) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NN NN profit N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN from (NP_213\NP_213)/NP_214>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_221/N_221>) (<L N NN NN renegotiation N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_229\NP_229)/NP_230>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_244/N_244>) (<T N 1 2> (<L N/N NN NN debt N_239/N_239>) (<L N NN NN instrument N>) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/PP VBN VBN received (S[pss]\NP_251)/PP_252>) (<T PP 0 2> (<L PP/NP IN IN from PP/NP_257>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Faberge N_266/N_266>) (<L N NNP NNP Inc. N>) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_280\NP_275)_280\(S_280\NP_275)_280)/NP_281>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN connection N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN with (NP_292\NP_292)/NP_293>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Lilly N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_302/N_302)\NP_303>) ) (<L N NN NN sale N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_314\NP_314)/NP_315>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Elizabeth N_331/N_331>) (<T N 1 2> (<L N/N NNP NNP Arden N_324/N_324>) (<L N NNP NNP Inc. N>) ) ) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_340\NP_340)/NP_341>) (<T NP 0 1> (<L N CD CD 1987 N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ net N_358/N_358>) (<L N NNS NNS proceeds N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN from (NP_367\NP_367)/NP_368>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_375/N_375>) (<L N NN NN settlement N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_383\NP_383)/NP_384>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN patent N_393/N_393>) (<L N NN NN litigation N>) ) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN at (NP_402\NP_402)/NP_403>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 0 1> (<L N NNP NNP Lilly N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_426/N_426)\NP_427>) ) (<T N 1 2> (<L N/N NNP NNP Hybritech N_419/N_419>) (<T N 1 2> (<L N/N NNP NNP Inc. N_412/N_412>) (<L N NN NN unit N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.26 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN Third-quarter N_360/N_360>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_369\NP_369)/NP_370>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_402/N_402>) (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) NNP NNP Indianapolis (N_397/N_391)_397/(N_397/N_391)_397>) (<T N/N 1 2> (<L , , , , ,>) (<T N/N 0 2> (<L N/N NNP NNP Ind. N_379/N_379>) (<L , , , , ,>) ) ) ) (<L N NN NN company N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD rose S[dcl]\NP_258>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 11 ((S_293\NP_285)_293\(S_286\NP_285)_286)_293/((S_293\NP_285)_293\(S_286\NP_285)_286)_293>) (<L (S\NP)\(S\NP) NN NN % (S_270\NP_265)_270\(S_270\NP_265)_270>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_306\NP_301)_306\(S_306\NP_301)_306)/NP_307>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_312>) (<T N[num] 1 2> (<L N/N CD CD 1.045 N_321/N_321>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN from ((S_335\NP_330)_335\(S_335\NP_330)_335)/NP_336>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_341>) (<T N[num] 1 2> (<L N/N CD CD 940.6 N_350/N_350>) (<L N[num] CD CD million N[num]>) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.27 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Nine-month N_273/N_273>) (<L N NNS NNS sales N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L S[dcl]\NP VBD VBD grew S[dcl]\NP_140>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) CD CD 12 ((S_175\NP_167)_175\(S_168\NP_167)_168)_175/((S_175\NP_167)_175\(S_168\NP_167)_168)_175>) (<L (S\NP)\(S\NP) NN NN % (S_152\NP_147)_152\(S_152\NP_147)_152>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_188\NP_183)_188\(S_188\NP_183)_188)/NP_189>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_194>) (<T N[num] 1 2> (<L N/N CD CD 3.39 N_203/N_203>) (<L N[num] CD CD billion N[num]>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN from ((S_217\NP_212)_217\(S_217\NP_212)_217)/NP_218>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_223>) (<T N[num] 1 2> (<L N/N CD CD 3.03 N_232/N_232>) (<L N[num] CD CD billion N[num]>) ) ) ) ) (<T ((S\NP)\(S\NP))\((S\NP)\(S\NP)) 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_264/N_264>) (<L N NN NN year N>) ) (<L (((S\NP)\(S\NP))\((S\NP)\(S\NP)))\NP RBR RBR earlier (((S_256\NP_246)_256\(S_248\NP_249)_247)_256\((S_256\NP_246)_256\(S_248\NP_249)_247)_256)\NP_257>) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.28 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS Sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_158\NP_158)/NP_159>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NNP NNP Prozac N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_169/N_169>) (<L N NN NN anti-depressant N>) ) ) ) (<L , , , , ,>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD led (S[dcl]\NP_136)/NP_137>) (<T NP 0 1> (<T N 1 2> (<L N/N NNS NNS drug-sales N_146/N_146>) (<L N NNS NNS increases N>) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.29 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJR JJR Higher N_193/N_193>) (<L N NNS NNS sales N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_202\NP_202)/NP_203>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS pesticides N>) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ other N_222/N_222>) (<T N 1 2> (<L N/N NN NN plant-science N_215/N_215>) (<L N NNS NNS products N>) ) ) ) ) ) ) ) (<T S[dcl]\NP 1 2> (<T (S\NP)/(S\NP) 1 2> (<L S[adj]\NP JJR RBR more S[adj]\NP_184>) (<L ((S\NP)/(S\NP))\(S[adj]\NP) IN IN than ((S_178\NP_171)_178/(S_178\NP_171)_178)\(S[adj]_179\NP_171:B)_179>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[to]\NP) 0 2> (<L ((S[dcl]\NP)/(S[to]\NP))/NP VBP VBP offset ((S[dcl]\NP_54)/(S[to]_55\NP_56:B)_55)/NP_56>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_70/N_70>) (<T N 1 2> (<L N/N JJ JJ slight N_65/N_65>) (<L N NN NN decline N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_78\NP_78)/NP_79>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_86/N_86>) (<L N NNS NNS sales N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_94\NP_94)/NP_95>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN animal-health N_104/N_104>) (<L N NNS NNS products N>) ) ) ) ) ) ) ) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_114)/(S[b]_115\NP_114:B)_115>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB fuel (S[b]\NP_122)/NP_123>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_130/N_130>) (<L N NN NN increase N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_138\NP_138)/NP_139>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ world-wide N_162/N_162>) (<T N 1 2> (<L N/N JJ JJ agricultural N_155/N_155>) (<T N 1 2> (<L N/N NN NN product N_148/N_148>) (<L N NNS NNS sales N>) ) ) ) ) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Lilly N>) ) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_37)\NP_38>) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.30 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Advanced N_232/N_232>) (<T N 1 2> (<L N/N NNP NNP Cardiovascular N_225/N_225>) (<T N 1 2> (<L N/N NNPS NNPS Systems N_218/N_218>) (<L N NNP NNP Inc. N>) ) ) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Cardiac N_256/N_256>) (<T N 1 2> (<L N/N NNPS NNPS Pacemakers N_249/N_249>) (<T N 1 2> (<L N/N NNP NNP Inc. N_242/N_242>) (<L N NNS NNS units N>) ) ) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD led (S[dcl]\NP_175)/NP_176>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN growth N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_187\NP_187)/NP_188>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_209/N_209>) (<T N 1 2> (<L N/N JJ JJ medical-instrument N_204/N_204>) (<T N 1 2> (<L N/N NNS NNS systems N_197/N_197>) (<L N NN NN division N>) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_2007.31 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Lilly N_194/N_194>) (<L N NNS NNS shares N>) ) ) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L (S[dcl]\NP)/PP VBD VBD closed (S[dcl]\NP_86)/PP_87>) (<L (S\NP)\(S\NP) NN NN yesterday (S_99\NP_94)_99\(S_99\NP_94)_99>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_112\NP_107)_112\(S_112\NP_107)_112)/NP_113>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ composite N_122/N_122>) (<L N NN NN trading N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN on (NP_131\NP_131)/NP_132>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_146/N_146>) (<T N 1 2> (<L N/N NNP NNP Big N_141/N_141>) (<L N NNP NNP Board N>) ) ) ) ) ) ) (<T PP 0 2> (<L PP/NP IN IN at PP/NP_151>) (<T NP 0 1> (<T N 0 2> (<L N/N[num] $ $ $ N/N[num]_156>) (<L N[num] CD CD 62.25 N[num]>) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN down ((S_174\NP_169)_174\(S_174\NP_169)_174)/NP_175>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 12.5 N_184/N_184>) (<L N NNS NNS cents N>) ) ) ) ) ) (<L . . . . .>) ) 
